NCT03069014[Secondary Source ID] - Search Results

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2023	1
2024	2
2025	0

Page 1

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial.

Shanks HRC, Chen K, Reiman EM, Blennow K, Cummings JL, Massa SM, Longo FM, Börjesson-Hanson A, Windisch M, Schmitz TW. Shanks HRC, et al. Nat Med. 2024 Jun;30(6):1761-1770. doi: 10.1038/s41591-024-02977-w. Epub 2024 May 17. Nat Med. 2024. PMID: 38760589 Free PMC article. Clinical Trial.

In vivo functions of p75^NTR: challenges and opportunities for an emerging therapeutic target.

Malik SC, Sozmen EG, Baeza-Raja B, Le Moan N, Akassoglou K, Schachtrup C. Malik SC, et al. Trends Pharmacol Sci. 2021 Sep;42(9):772-788. doi: 10.1016/j.tips.2021.06.006. Epub 2021 Jul 29. Trends Pharmacol Sci. 2021. PMID: 34334250 Free PMC article. Review.

Axonal injury mediated by neuronal p75NTR/TRAF6/JNK pathway contributes to cognitive impairment after repetitive mTBI.

Liu G, He M, Wu C, Lv P, Sun H, Wang H, Xin X, Liao H. Liu G, et al. Exp Neurol. 2024 Feb;372:114618. doi: 10.1016/j.expneurol.2023.114618. Epub 2023 Nov 27. Exp Neurol. 2024. PMID: 38029807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year